Suppr超能文献

镁作为一种新兴的用于骨科应用的生物活性材料:床边需求引领从创新到临床转化之路。

Magnesium as an emerging bioactive material for orthopedic applications: bedside needs lead the way from innovation to clinical translation.

作者信息

Zhang Ningze, Zhang Qida, Shao Hongwei, Shan Zhengming, Xu Jiankun, Tong Wenxue, Wong Ronald Man Yeung, Qin Ling

机构信息

Musculoskeletal Research Laboratory, Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.

Innovative Orthopaedic Biomaterial and Drug Translational Research Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.

出版信息

Regen Biomater. 2025 Apr 26;12:rbaf032. doi: 10.1093/rb/rbaf032. eCollection 2025.

Abstract

With the rapid increase in population aging, the number of surgical operations in orthopedics is expected to increase. The gap between the materials applied in clinical orthopedics and materials in discovery and research is obvious due to regulatory requirements for biosafety and treatment efficacy. For the bedside needs, it is important to overcome hurdles by achieving impactful innovation and clinical translation of orthopedic materials. Magnesium (Mg), as an emerging bioactive material, is one of the vital components of the human body and mainly stored in the musculoskeletal system as either a matrix component or an intracellular element for the homeostasis of various physiological functions. However, the degradation and biomechanical performance limit the applications of Mg. This review aims to explore the current challenges and future directions of Mg for clinical translation and provide an update on biomaterials used in orthopedics, factors driving orthopedic innovation, physiology of magnesium ions (Mg) and its potential clinical applications. To achieve orthopedic application, modification of the performance of Mg as implantable metals and function of the degradation products of Mg are described. For the clinical needs of treating the steroid-associated osteonecrosis (SAON), Mg screws and Mg-based composite porous scaffolds (Mg/PLGA/TCP: magnesium/poly(lactic-co-glycolic acid) (PLGA)/tricalcium phosphate (TCP)) have been developed, but the challenges of Mg-based implants in load-bearing skeletal sites still exist. To utilize the beneficial biological effects of Mg degradation and overcome the weakness in mechanical stability for fracture fixation, the concept of developing Mg/titanium (Ti) hybrid orthopedic implants is reported, where the Ti component provides effective mechanical support while the inclusion of Mg component potentially optimizes the biomechanical properties of Ti component and facilitate bone healing. This review provides a reference frame for the translation of novel materials and promotes the development of innovative orthopedic biomaterials for clinical applications.

摘要

随着人口老龄化的迅速加剧,预计骨科手术的数量将会增加。由于对生物安全性和治疗效果的监管要求,临床骨科应用的材料与发现和研究中的材料之间的差距十分明显。对于床边需求而言,通过实现骨科材料的重大创新和临床转化来克服障碍至关重要。镁(Mg)作为一种新兴的生物活性材料,是人体的重要组成部分之一,主要作为基质成分或细胞内元素存储在肌肉骨骼系统中,以维持各种生理功能的稳态。然而,镁的降解和生物力学性能限制了其应用。本综述旨在探讨镁临床转化的当前挑战和未来方向,并提供骨科生物材料、推动骨科创新的因素、镁离子(Mg)的生理学及其潜在临床应用的最新信息。为实现骨科应用,描述了作为可植入金属的镁的性能改性以及镁降解产物的功能。针对治疗类固醇相关骨坏死(SAON)的临床需求,已开发出镁螺钉和镁基复合多孔支架(Mg/PLGA/TCP:镁/聚(乳酸-共-乙醇酸)(PLGA)/磷酸三钙(TCP)),但镁基植入物在承重骨骼部位仍存在挑战。为了利用镁降解的有益生物学效应并克服骨折固定中机械稳定性的弱点,报道了开发镁/钛(Ti)混合骨科植入物的概念,其中钛成分提供有效的机械支撑,而镁成分的加入可能优化钛成分的生物力学性能并促进骨愈合。本综述为新型材料的转化提供了参考框架,并促进了用于临床应用的创新骨科生物材料的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782d/12094927/8c7308a0fec3/rbaf032f8.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验